News & Updates

Show Multimedia Only

LHRH analogues vs tE2 patches: Which work best for prostate cancer?

02 May 2025 by

The use of transdermal oestradiol (tE2) or oestrogen patches helps suppress testosterone and prostate-specific antigen (PSA) in men with locally advanced prostate cancer, with similar efficacy to that of luteinizing hormone-releasing hormone (LHRH) analogues, reports a study presented at EAU 2025.

LHRH analogues vs tE2 patches: Which work best for prostate cancer?

02 May 2025

Breastfeeding reduces risk of infant RTIs

02 May 2025

Infants who have been fully breastfed for 6 months up to at least 1 year appear to have a lower risk of subsequent respiratory tract infections (RTIs) and hospitalization from RTIs, a study has shown.

Breastfeeding reduces risk of infant RTIs

02 May 2025

MSC therapy delivers long-term benefit in severe COVID-19

02 May 2025 by

A recent study suggests patients with severe COVID-19 may benefit from human mesenchymal stem cell (MSC) therapy.

MSC therapy delivers long-term benefit in severe COVID-19

02 May 2025

Diet plus physical activity mitigates weight loss-related decline in BMD in older women

02 May 2025

In older women with metabolic syndrome, a lifestyle intervention based on energy-reduced Mediterranean diet plus physical activity lifestyle appears to mitigate the effects of weight loss on bone mineral density (BMD), according to the results of the 3-year, parallel-group PREDIMED-Plus trial.

Diet plus physical activity mitigates weight loss-related decline in BMD in older women

02 May 2025

Primary stroke mechanism identification helps predict recurrent stroke risk

02 May 2025 by

In medically treated symptomatic intracranial atherosclerotic stenosis (sICAS) patients, considering artery-to-artery embolism (AAE) rather than hypoperfusion as the stroke mechanism for cortical borderzone (CBZ) infarcts could better predict early recurrent stroke in the same territory (SIT), a study by the Chinese University of Hong Kong (CUHK) has found.

Primary stroke mechanism identification helps predict recurrent stroke risk

02 May 2025

Palliative care needed in patients with progressive neurologic diseases

02 May 2025 by

Early recognition and management of emerging palliative care (PC) needs, particularly psychospiritual distress, is crucial for enhancing health-related quality of life (HRQoL) for patients with peripheral neurologic diseases (PNDs), a study by the University of Hong Kong (HKU) has found.

Palliative care needed in patients with progressive neurologic diseases

02 May 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

New drug applications approved by US FDA as of 1-15 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

Higher muscle strength associated with lower T2D risk

02 May 2025 by

Higher muscle strength is associated with lower relative risk of developing type 2 diabetes (T2D), irrespective of genetic susceptibility to T2D, while such association is weaker in the high genetic risk group, researchers from the University of Hong Kong (HKU) have found.

Higher muscle strength associated with lower T2D risk

02 May 2025

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

01 May 2025 by

In the management of diabetes, users of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have a lower risk of all-cause dementia compared with users of other glucose-lowering medications, according to a systematic review and meta-analysis.

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

01 May 2025

Self-efficacy high among survivors of prostate cancer

01 May 2025 by

Long-term prostate cancer survivors report high levels of self-efficacy, but the contrary is true for subgroups who are facing some challenges, a study presented at EAU 2025 has found.

Self-efficacy high among survivors of prostate cancer

01 May 2025

News & Updates

Filter by Specialty:

Specialty:

LHRH analogues vs tE2 patches: Which work best for prostate cancer?

LHRH analogues vs tE2 patches: Which work best for prostate cancer?

Breastfeeding reduces risk of infant RTIs

Breastfeeding reduces risk of infant RTIs

MSC therapy delivers long-term benefit in severe COVID-19

MSC therapy delivers long-term benefit in severe COVID-19

Diet plus physical activity mitigates weight loss-related decline in BMD in older women

Diet plus physical activity mitigates weight loss-related decline in BMD in older women

Primary stroke mechanism identification helps predict recurrent stroke risk

Primary stroke mechanism identification helps predict recurrent stroke risk

Palliative care needed in patients with progressive neurologic diseases

Palliative care needed in patients with progressive neurologic diseases

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

Higher muscle strength associated with lower T2D risk

Higher muscle strength associated with lower T2D risk

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

Meta-analysis favours glucose-lowering with GLP-1RA for dementia risk

Self-efficacy high among survivors of prostate cancer

Self-efficacy high among survivors of prostate cancer